TY - JOUR
T1 - Approaches to decision-making among late-stage melanoma patients
T2 - a multifactorial investigation
AU - Garrett, Sarah B.
AU - Abramson, Corey M.
AU - Rendle, Katharine A.
AU - Dohan, Daniel
N1 - Funding Information:
Funding Research reported in this article was partially funded through a Patient-Centered Outcomes Research Institute® (PCORI®) Award (ME-1409-22996). The statements presented in this article are solely the responsibility of the authors and do not necessarily represent the views of PCORI®, its Board of Governors or Methodology Committee. Financial support for this study was also provided in part by a grant from the National Cancer Institute (R01 CA152195; Daniel Dohan, principal investigator). The funding agreement ensured the authors’ independence in designing the study, interpreting the data, writing, and publishing the report. The content presented here is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health.
Publisher Copyright:
© 2018, The Author(s).
PY - 2019/3/1
Y1 - 2019/3/1
N2 - Purpose: The treatment decisions of melanoma patients are poorly understood. Most research on cancer patient decision-making focuses on limited components of specific treatment decisions. This study aimed to holistically characterize late-stage melanoma patients’ approaches to treatment decision-making in order to advance understanding of patient influences and supports. Methods: (1) Exploratory analysis of longitudinal qualitative data to identify themes that characterize patient decision-making. (2) Pattern analysis of decision-making themes using an innovative method for visualizing qualitative data: a hierarchically-clustered heatmap. Participants were 13 advanced melanoma patients at a large academic medical center. Results: Exploratory analysis revealed eight themes. Heatmap analysis indicated two broad types of patient decision-makers. “Reliant outsiders” relied on providers for medical information, demonstrated low involvement in decision-making, showed a low or later-in-care interest in clinical trials, and expressed altruistic motives. “Active insiders” accessed substantial medical information and expertise in their networks, consulted with other doctors, showed early and substantial interest in trials, demonstrated high involvement in decision-making, and employed multiple decision-making strategies. Conclusion: We identified and characterized two distinct approaches to decision-making among patients with late-stage melanoma. These differences spanned a wide range of factors (e.g., behaviors, resources, motivations). Enhanced understanding of patients as decision-makers and the factors that shape their decision-making may help providers to better support patient understanding, improve patient-provider communication, and support shared decision-making.
AB - Purpose: The treatment decisions of melanoma patients are poorly understood. Most research on cancer patient decision-making focuses on limited components of specific treatment decisions. This study aimed to holistically characterize late-stage melanoma patients’ approaches to treatment decision-making in order to advance understanding of patient influences and supports. Methods: (1) Exploratory analysis of longitudinal qualitative data to identify themes that characterize patient decision-making. (2) Pattern analysis of decision-making themes using an innovative method for visualizing qualitative data: a hierarchically-clustered heatmap. Participants were 13 advanced melanoma patients at a large academic medical center. Results: Exploratory analysis revealed eight themes. Heatmap analysis indicated two broad types of patient decision-makers. “Reliant outsiders” relied on providers for medical information, demonstrated low involvement in decision-making, showed a low or later-in-care interest in clinical trials, and expressed altruistic motives. “Active insiders” accessed substantial medical information and expertise in their networks, consulted with other doctors, showed early and substantial interest in trials, demonstrated high involvement in decision-making, and employed multiple decision-making strategies. Conclusion: We identified and characterized two distinct approaches to decision-making among patients with late-stage melanoma. These differences spanned a wide range of factors (e.g., behaviors, resources, motivations). Enhanced understanding of patients as decision-makers and the factors that shape their decision-making may help providers to better support patient understanding, improve patient-provider communication, and support shared decision-making.
KW - Decision making
KW - Ethnoarray approach
KW - Ethnography
KW - Melanoma
UR - http://www.scopus.com/inward/record.url?scp=85052658415&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85052658415&partnerID=8YFLogxK
U2 - 10.1007/s00520-018-4395-7
DO - 10.1007/s00520-018-4395-7
M3 - Article
C2 - 30136025
AN - SCOPUS:85052658415
SN - 0941-4355
VL - 27
SP - 1059
EP - 1070
JO - Supportive Care in Cancer
JF - Supportive Care in Cancer
IS - 3
ER -